Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column

Masato Kiyoshi, Jose M.M. Caaveiro, Minoru Tada, Hiroko Tamura, Toru Tanaka, Yosuke Terao, Koldo Morante, Akira Harazono, Noritaka Hashii, Hiroko Shibata, Daisuke Kuroda, Satoru Nagatoishi, Seigo Oe, Teruhiko Ide, Kouhei Tsumoto, Akiko Ishii-Watabe

研究成果: Contribution to journalArticle

10 引用 (Scopus)

抜粋

The N-glycan moiety of IgG-Fc has a significant impact on multifaceted properties of antibodies such as in their effector function, structure, and stability. Numerous studies have been devoted to understanding its biological effect since the exact composition of the Fc N-glycan modulates the magnitude of effector functions such as the antibody-dependent cell mediated cytotoxicity (ADCC), and the complement-dependent cytotoxicity (CDC). To date, systematic analyses of the properties and influence of glycan variants have been of great interest. Understanding the principles on how N-glycosylation modulates those properties is important for the molecular design, manufacturing, process optimization, and quality control of therapeutic antibodies. In this study, we have separated a model therapeutic antibody into three fractions according to the composition of the N-glycan by using a novel FcγRIIIa chromatography column. Notably, Fc galactosylation was a major factor influencing the affinity of IgG-Fc to the FcγRIIIa immobilized on the column. Each antibody fraction was employed for structural, biological, and physicochemical analysis, illustrating the mechanism by which galactose modulates the affinity to FcγRIIIa. In addition, we discuss the benefits of the FcγRIIIa chromatography column to assess the heterogeneity of the N-glycan.

元の言語英語
記事番号3955
ジャーナルScientific Reports
8
発行部数1
DOI
出版物ステータス出版済み - 12 1 2018

All Science Journal Classification (ASJC) codes

  • General

フィンガープリント Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Kiyoshi, M., Caaveiro, J. M. M., Tada, M., Tamura, H., Tanaka, T., Terao, Y., Morante, K., Harazono, A., Hashii, N., Shibata, H., Kuroda, D., Nagatoishi, S., Oe, S., Ide, T., Tsumoto, K., & Ishii-Watabe, A. (2018). Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column. Scientific Reports, 8(1), [3955]. https://doi.org/10.1038/s41598-018-22199-8